These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24698542)

  • 1. Biomolecular markers in assessment and treatment of asthma.
    Fatemi F; Sadroddiny E; Gheibi A; Mohammadi Farsani T; Kardar GA
    Respirology; 2014 May; 19(4):514-23. PubMed ID: 24698542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory biomarkers in severe asthma.
    Chung KF
    Curr Opin Pulm Med; 2012 Jan; 18(1):35-41. PubMed ID: 22045348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in asthma biomarker research.
    Leung TF; Ko FW; Wong GW
    Ther Adv Respir Dis; 2013 Oct; 7(5):297-308. PubMed ID: 23907809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
    Vijverberg SJ; Koenderman L; Koster ES; van der Ent CK; Raaijmakers JA; Maitland-van der Zee AH
    Clin Exp Allergy; 2011 May; 41(5):615-29. PubMed ID: 21488995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of biomarkers in the management of airways disease.
    Baines KJ; Pavord ID; Gibson PG
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1264-8. PubMed ID: 25299856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of measurement of two specific biomarkers for the assessment of small airways inflammation in asthma.
    Kanazawa H; Kyoh S; Asai K; Hirata K
    J Asthma; 2010 May; 47(4):400-6. PubMed ID: 20528593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods used in clinical development of novel anti-asthma therapies.
    Diamant Z; Boot D; Kamerling I; Bjermer L
    Respir Med; 2008 Mar; 102(3):332-8. PubMed ID: 18061420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory markers in exhaled breath condensate from patients with asthma.
    Ueno T; Kataoka M; Hirano A; Iio K; Tanimoto Y; Kanehiro A; Okada C; Soda R; Takahashi K; Tanimoto M
    Respirology; 2008 Sep; 13(5):654-63. PubMed ID: 18513240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Noninvasive methods of assessing inflammation in bronchial asthma].
    Grigoraş C; Mihăescu T
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):632-7. PubMed ID: 18293692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.
    Zacharasiewicz A; Wilson N; Lex C; Erin EM; Li AM; Hansel T; Khan M; Bush A
    Am J Respir Crit Care Med; 2005 May; 171(10):1077-82. PubMed ID: 15709050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease.
    Kharitonov SA; Barnes PJ
    Proc Am Thorac Soc; 2004; 1(3):191-9. PubMed ID: 16113434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of FeNO measurement in asthma management: the motion for Yes, it's NO--or, the wrong end of the Stick!
    Bush A; Eber E
    Paediatr Respir Rev; 2008 Jun; 9(2):127-31. PubMed ID: 18513673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway inflammation and bronchial hyperreactivity in steroid naive children with intermittent and mild persistent asthma.
    Toyran M; Bakirtas A; Dogruman-Al F; Turktas I
    Pediatr Pulmonol; 2014 Feb; 49(2):140-7. PubMed ID: 23798479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of inflammation in asthma: a clinical perspective.
    Taylor DR
    Semin Respir Crit Care Med; 2012 Dec; 33(6):620-9. PubMed ID: 23047312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory phenotypes in stable and acute childhood asthma.
    He XY; Simpson JL; Wang F
    Paediatr Respir Rev; 2011 Sep; 12(3):165-9. PubMed ID: 21722844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma.
    Barbaro MP; Spanevello A; Palladino GP; Salerno FG; Lacedonia D; Carpagnano GE
    Eur J Intern Med; 2014 Jan; 25(1):92-6. PubMed ID: 24070522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periostin, a novel biomarker of TH2-driven asthma.
    Parulekar AD; Atik MA; Hanania NA
    Curr Opin Pulm Med; 2014 Jan; 20(1):60-5. PubMed ID: 24247042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma.
    Boot JD; Panzner P; Diamant Z
    Pulm Pharmacol Ther; 2007; 20(3):201-19. PubMed ID: 16584905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
    Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
    J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.